Clinical Trial Update: Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics [NA]

View source ↗

Summary

Clinical trial update on the efficacy of TBCT, MBHP, and PPT for PTSD during the COVID-19 pandemic; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MBHP
• PPT
• TBCT

Snippet

Sponsor: Fundação Bahiana de Infectologia | Conditions: Posttraumatic Stress Disorder, Covid19 | NA | Status: TERMINATED